Cargando…
Insertable cardiac monitor‐guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol (ICM‐REDUCE‐AF trial)
BACKGROUND: Percutaneous catheter ablation (CA) to achieve pulmonary vein isolation is an effective treatment for drug‐refractory paroxysmal and persistent atrial fibrillation (AF). However, recurrence rates after a single AF ablation procedure remain elevated. Conventional management after CA ablat...
Autores principales: | Tankut, Sinan S., Huang, David T., Zareba, Wojciech, Aktas, Mehmet K., Rosero, Spencer Z., Steinberg, Jonathan, Henchen, Jennifer, Kutyifa, Valentina, Strawderman, Robert L., Goldenberg, Ilan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023887/ https://www.ncbi.nlm.nih.gov/pubmed/36718801 http://dx.doi.org/10.1111/anec.13043 |
Ejemplares similares
-
Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)
por: Aktas, Mehmet K., et al.
Publicado: (2020) -
Need for pacing in patients who qualify for an implantable cardioverter‐defibrillator: Clinical implications for the subcutaneous ICD
por: Kutyifa, Valentina, et al.
Publicado: (2020) -
Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023) -
Confirm Rx insertable cardiac monitor for primary atrial fibrillation detection in high‐risk heart failure patients (Confirm‐AF trial)
por: Aktas, Mehmet K., et al.
Publicado: (2022) -
Risk factors for ventricular tachyarrhythmic events in patients without left bundle branch block who receive cardiac resynchronization therapy
por: Younis, Arwa, et al.
Publicado: (2021)